Trials / Conditions / Primary Cutaneous Anaplastic Large Cell Lymphoma
Primary Cutaneous Anaplastic Large Cell Lymphoma
6 registered clinical trials studyying Primary Cutaneous Anaplastic Large Cell Lymphoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Registry for People With T-cell Lymphoma NCT05978141 | Memorial Sloan Kettering Cancer Center | — |
| Completed | Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymp NCT03409432 | John Reneau | Phase 2 |
| Completed | Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma NCT02652715 | Mayo Clinic | N/A |
| Active Not Recruiting | Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency NCT01787409 | Mayo Clinic | N/A |
| Completed | A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Parti NCT01578499 | Millennium Pharmaceuticals, Inc. | Phase 3 |
| Completed | Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma NCT01134341 | Acrotech Biopharma Inc. | Phase 1 |